文献速递青光眼

小梁切除术中丝裂霉素C结膜下注射与巩膜直接应用的随机对照试验

A Randomized Controlled Trial Comparing Subconjunctival Injection to Direct Scleral Application of Mitomycin C in Trabeculectomy.
PubMed 文献 · Am J Ophthalmol · 2020-07-06

该前瞻性随机对照试验纳入100例药物未控制青光眼患者,比较小梁切除术中丝裂霉素C结膜下注射与巩膜海绵直接应用的效果。6个月时两组手术成功率、平均眼压、降眼压药物数量、滤过泡形态及并发症率均无显著差异。

要点

  • 结膜下注射与巩膜直接应用丝裂霉素C在小梁切除术中效果相当。
  • 两组6个月手术成功率、眼压、用药数及滤过泡形态均无显著差异。
  • 两种丝裂霉素C给药方式的并发症率无显著差异。

核心结论

  • 结膜下注射与巩膜直接应用丝裂霉素C在小梁切除术中产生可比的手术结局和滤过泡形态。

研究设计与样本

  • 前瞻性随机干预研究,在学术机构单一临床实践中进行,纳入100例药物未控制的青光眼患者。
  • 患者随机接受术前结膜下注射或术中巩膜海绵直接应用丝裂霉素C,术后随访6个月。

关键数值与推荐

  • 主要结局为眼压<21 mm Hg且较基线下降≥30%的患者比例。
  • 次要结局包括降眼压药物数量、Indiana滤过泡外观分级评分及并发症率。

临床怎么用

  • 小梁切除术中丝裂霉素C可采用结膜下注射或巩膜直接应用,两者效果相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the efficacy of intraoperative scleral application with subconjunctival injection of mitomycin C (MMC) in trabeculectomy. DESIGN: Prospective, randomized, interventional study. METHODS: This study took place in a single clinical practice in an academic setting. Patients had medically uncontrolled glaucoma as indicated by high intraocular pressure (IOP), worsening visual field, or optic nerve head changes in whom primary trabeculectomy was indicated. Patients were older than 18 years with medically uncontrolled glaucoma and no history of incisional glaucoma surgery. Patients were randomized to MMC delivered by preoperative subconjunctival injection or by intraoperative direct scleral application using surgical sponges during trabeculectomy. Comprehensive eye examinations were conducted at 1 day, 1 week, 6 weeks, 3 months, and 6 months postoperatively. Subconjunctival 5-fluorouracil injections were given postoperatively, as needed. The primary outcome was the proportion of patients who demonstrated IOP of <21 mm Hg and ≥30% reduction in IOP from baseline. Secondary outcome measures included the number of IOP-lowering medications, bleb morphology using the Indiana Bleb Appearance Grading Scale, and complication rates. RESULTS: Participants (n = 100) were randomized into groups matched for baseline demographics, glaucoma status, and baseline IOP. At 6 months, there were no significant differences between the injection (n = 38) and sponge (n = 40) groups in surgical success (P = .357), mean IOP (P = .707), number of glaucoma medications (P = 1.000), bleb height (P = .625), bleb extension (P = .216), bleb vascularity (P = .672), or complications rates. CONCLUSION: Both techniques of MMC delivery (subconjunctival injection and direct scleral application) resulted in comparable surgical outcomes and bleb morphologies.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Do JL, Xu BY, Wong B, et al. A Randomized Controlled Trial Comparing Subconjunctival Injection to Direct Scleral Application of Mitomycin C in Trabeculectomy. Am J Ophthalmol. 2020. PMID: 32645310. doi:10.1016/j.ajo.2020.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。